IL2 and neoplasm: To investigate whether proliferation can also be observed in patient-derived tumor-infiltrating cells, we stimulated ex vivo –isolated Vδ2 TILs within tumor tissue with either medium or ETA-067, along with the repeated addition of IL-2 (every 3 days).